Q&A With John Teerlink From University of California San Francisco: New Medication Shows Early Promise for Heart Failure Treatment

There are medications currently available to help patients diagnosed with heart failure but many do not address quality of life of these patients after treatment. A new medication being investigated could help with both issues of patient care.

John Teerlink, MD, from the University of San Francisco discussed the resuts of the COSMIC-HF trial during the annual meeting of the American Heart Association in Orlando. The study involves an oral form of omecamtiv mecarbil which would be a novel approach to treating the condition.